The systemic lupus erythematosus Tri-Nation study: cumulative indirect costs.

P, Panopalis; M, Petri; S, Manzi; DA, Isenberg; C, Gordon; JL, Senécal; JR, Penrod; L, Joseph; Pierre Y, St; C, Pineau; PR, Fortin; N, Sutcliffe; JR, Goulet; D, Choquette; T, Grodzicky; JM, Esdaile; AE, Clarke

doi:10.1002/art.22470

Public

The systemic lupus erythematosus Tri-Nation study: cumulative indirect costs.

Shared by NobleBlocks on Feb 1, 2007 • 12:00 AM UTC

Authors:

Panopalis P

Petri M

Manzi S

Abstract

Objective We previously reported that patients with systemic lupus erythematosus (SLE) in the US incurred approximately 19% and 12% higher direct medical costs than patients in Canada and the UK, respectively, without experiencing superior outcomes expressed as disease damage or quality of life. In ...

Discussions